<DOC>
	<DOCNO>NCT01587027</DOCNO>
	<brief_summary>This safety study first series study test application combination aminophylline methazolamide .</brief_summary>
	<brief_title>Safety Evaluation Aminophylline Methazolamide</brief_title>
	<detailed_description>After successful completion safety trial , goal evaluate safety combination healthy individual expose hypoxia exercise . Subsequently , efficacy study clarify whether drug combination improve physical mental function human subject high altitude condition .</detailed_description>
	<mesh_term>Altitude Sickness</mesh_term>
	<mesh_term>Theophylline</mesh_term>
	<mesh_term>Aminophylline</mesh_term>
	<mesh_term>Methazolamide</mesh_term>
	<criteria>Subjects must healthy nonsmoking adult male female volunteer age 18 40 year , BMI 1830 kg/m2 weight least 150 lb . Women childbearing potential , must , sexually active , must agree use appropriate contraceptive measure duration study one ( 1 ) month afterwards . Subjects must agree donate blood , plasma , platelet , blood component study 4 week last dose . History manifestation clinically significant neurological , gastrointestinal , renal , hepatic , cardiovascular , psychological , pulmonary , metabolic , endocrine , hematologic medical disorder . Serious mental physical illness within past year . History clinically significant illness within 4 week prior Day 1 . History allergic reaction , hypersensitivity idiosyncratic reaction product administer study , include allergy sulfa sulfonamide derivative . Use follow : Any concomitant medication . Subjects receive prescribed nonprescribed ( overthecounter [ OTC ] ) systemic medication , topical medication , herbal supplement within 14 day Day 1 . St. John 's Wort ( hypericin ) must take least 30 day prior Period 1 , Day 1 . Any drug , food substance know strong inhibitor strong inducer CYP enzyme ( also know cytochrome P450 enzyme ) ; especially CYP 1A2 , Pgp within 30 day prior Period 1 , Day 1 . Currently abuse drug alcohol history drug alcohol abuse within past two year . Positive result screen test drug abuse , cotinine alcohol screen predose assessment checkin . Clinically significant ECG abnormality , opinion Investigator . Use tobacco product nicotinecontaining product ( include smoke cessation aid , gum patch ) 14 day screen throughout hospitalization . Subjects childbearing potential pregnant ( base test result ) breast feed . Has take investigational drug 30 day prior screen visit currently participate another investigational clinical trial . Subjects make significant donation ( include plasma ) significant loss blood within 30 day prior Period 1 , Day 1 . Receipt transfusion blood product within 30 day prior Period 1 , Day 1 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Altitude Sickness</keyword>
	<keyword>High Altitude Sickness</keyword>
</DOC>